. 2021 Nov 18;45(2):333–343. doi: 10.1038/s41440-021-00798-9

Table 2.

Differences between survived and deceased hypertensive patients

Variables	Deceased hypertensive patients	Survived hypertensive patients	P value
Demographic and clinical variables
Number of patients, n/N (%)	238 (27, 3)	633 (72, 6)
Age, years, ±SD	77.9 ± 9	70 ± 11	0.001
Sex, n/N (%)	56 (6, 5)	231 (27)	0.001
Type 2 diabetes mellitus, n/N (%)	75 (8, 8)	148 (17, 3)	0.009
History of CAD, n/N (%)	49 (5, 7)	90 (10, 5)	0.016
History of Atrial Fibrillation, n/N (%)	44 (5, 2)	67 (7, 9)	0.001
History of PAD, n/N (%)	32 (3, 7)	39 (4, 6)	0.001
History of smoking, n/N (%)	14 (2, 3)	36 (6)	0.49
Chronic lung disease, n/N (%)	45 (5, 3)	68 (7, 9)	0.001
Previous oncological malignancy, n/N (%)	10 (1, 2)	33 (3, 9)	0.57
Laboratory values
Hemoglobin, g/dl ± SD	13 ± 2	13.3 ± 2	0.21
Creatinine, mg/dl ± SD	1.6 ± 1	1.1 ± 0.5	0.001
White blood cells, n/1000 ± SD	8260 ± 4000	7500 ± 3720	0.011
C-Reactive protein, mg/dl ± SD	14 ± 9	11 ± 9	0.001
LDH, u/l ± SD	496 ± 279	371 ± 212	0.001
Respiratory variables
Baseline on air oxygen saturation, n ± SD (%)	87 ± 9	90 ± 11	0.001
Lung CT interstitial involvement <25%, n/N (%)	70 (8, 2)	195 (22, 8)	0.81
Lung CT interstitial involvement 25–50%, n/N (%)	98 (11, 4)	281 (32, 8)	0.51
Lung CT interstitial involvement 50–75%, n/N (%)	52 (6, 1)	121 (14, 1)	0.303
Lung CT interstitial involvement >75%, n/N (%)	8 (0, 9)	20 (2, 3)	0.84
Cardio-thoracic vascular calcifications
Coronary calcium volume, mm³	44 (0–426)	31 (0–247)	0.1
LAD coronary calcium volume, mm³	17 (0–211)	13.5 (0–119)	0.027
Thoracic aorta calcium volume, mm³	432 (15–2703)	371 (19–2366)	0.36
Aortic valve calcium volume, mm³	0 (0–57)	0 (0–85)	0.35
Outcomes
Orotracheal intubation	17 (2)	146 (17)	0.001
Pulmonary embolism, n/N (%)	4 (0, 5)	20 (2, 3)	0.24
Acute coronary syndrome, n/N (%)	4 (0, 5)	3 (0, 4)	0.071
Stroke, n/N (%)	9 (1, 1)	7 (0, 8)	0.008

Descriptive table with the characteristics of surviving and deceased hypertensive patients